MBX Biosciences, Inc. (MBX)
NASDAQ: MBX · Real-Time Price · USD
40.97
+6.26 (18.02%)
At close: May 8, 2026, 4:00 PM EDT
41.00
+0.03 (0.09%)
After-hours: May 8, 2026, 7:32 PM EDT
MBX Biosciences Market Cap
MBX Biosciences has a market cap or net worth of $1.95 billion as of May 8, 2026. Its market cap has increased by 528.94% in one year.
Market Cap
1.95B
Enterprise Value
1.58B
1-Year Change
528.94%
Ranking
Category
Stock Price
$40.97
Market Cap Chart
Since the IPO on September 13, 2024, MBX Biosciences's market cap has increased from $509.66M to $1.95B, an increase of 282.36%. That is a compound annual growth rate of 125.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 1.95B | 37.60% |
| Dec 31, 2025 | 1.42B | 129.95% |
| Dec 31, 2024 | 615.88M | 20.84% |
| Sep 13, 2024 | 509.66M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Immunocore Holdings | 1.56B |
| Bicara Therapeutics | 1.56B |
| Precigen | 1.56B |
| Immatics | 1.54B |
| Novavax | 1.54B |
| AtaiBeckley | 1.53B |
| AbCellera Biologics | 1.53B |
| Biohaven | 1.51B |